World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
11521
World Ranking
2969
National Ranking
1397

Miroslaw K. Gorny publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Miroslaw K. Gorny sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 173 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Miroslaw K. Gorny D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Miroslaw K. Gorny sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Miroslaw K. Gorny is affiliated with New York University in the United States. Their research spans multiple fields within biomedical science, with a focus on immunology and microbiology as well as medicine.

Their main research interests include HIV research and treatment, monoclonal and polyclonal antibodies research, and the study of immune cell function and interaction. Other topics explored in their work include peptidase inhibition and analysis, radiopharmaceutical chemistry and applications, RNA modifications and cancer, and virology and viral diseases.

The subfields of study relevant to their publications include virology, immunology, radiology, nuclear medicine and imaging, infectious diseases, and molecular biology.

Frequent coauthors working alongside Miroslaw K. Gorny include Liuzhe Li, Ann J. Hessell, Xiaohong Wang, Michael Tuen, and David C. Montefiori.

The venues where their work has been published include:

  • Nuclear Medicine and Biology
  • The Journal of Immunology
  • Japanese Journal of Infectious Diseases
  • Vaccine
  • Human Vaccines & Immunotherapeutics

Selected recent papers by Miroslaw K. Gorny:

  • Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells, 2020, Nuclear Medicine and Biology
  • Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone, 2021, The Journal of Immunology
  • Prediction of Contact Residues in Anti-HIV Neutralizing Antibody by Deep Learning, 2020, Japanese Journal of Infectious Diseases
  • A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque, 2021, Vaccine
  • Search for antiviral functions of potentially protective antibodies against V2 region of HIV-1, 2020, Human Vaccines & Immunotherapeutics

Best Publications

  • Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1

    A Pinter;W J Honnen;S A Tilley;C Bona

  • Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

    M K Gorny;A J Conley;S Karwowska;A Buchbinder

  • The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection.

    Abraham Pinter;William J. Honnen;Yuxian He;Miroslaw K. Gorny

  • Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Allan deCamp;Peter Hraber;Robert T. Bailer;Michael S. Seaman

  • Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.

    M. K. Gorny;Jian-Yin Xu;S. Karwowska;A. Buchbinder

  • Role of Virion-associated Glycosylphosphatidylinositol-linked Proteins CD55 and CD59 in Complement Resistance of Cell Line-derived and Primary Isolates of HIV-1

    Mohammed Saifuddin;Charles J. Parker;Mark E. Peeples;Miroslaw K. Gorny

  • Generation of human monoclonal antibodies to human immunodeficiency virus

    Miroslaw K. Gorny;Vasiliki Gianakakos;Sandra Sharpe;Susan Zolla-Pazner

  • Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.

    J Y Xu;M K Gorny;T Palker;S Karwowska

  • Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D.

    A J Conley;M K Gorny;J A Kessler;L J Boots

  • Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D

    Robyn L. Stanfield;Miroslaw K. Gorny;Constance Williams;Susan Zolla-Pazner

  • Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.

    C M Hill;H Deng;D Unutmaz;V N Kewalramani

  • Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

    M K Gorny;J P Moore;A J Conley;S Karwowska

  • Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

    Miroslaw K. Gorny;Constance Williams;Barbara Volsky;Kathy Revesz

  • Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

    Miroslaw K. Gorny;Jian-Yin Xu;Vasiliki Gianakakos;Sylvia Karwowska

  • Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection

    S. Munir Alam;Richard M. Scearce;Robert J. Parks;Kelly Plonk

  • Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.

    Andreas Gigler;Simone Dorsch;Andrea Hemauer;Constance Williams

  • Conserved structural elements in the V3 crown of HIV-1 gp120.

    Xunqing Jiang;Valicia Burke;Maxim Totrov;Constance Williams

  • Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes

    Catarina E. Hioe;Catarina E. Hioe;Terri Wrin;Michael S. Seaman;Xuesong Yu

  • Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles

    Miroslaw K. Gorny;Leonidas Stamatatos;Barbara Volsky;Kathy Revesz

  • Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity

    Robyn L. Stanfield;Miroslaw K. Gorny;Susan Zolla-Pazner;Ian A. Wilson

Frequent Co-Authors

Susan Zolla-Pazner
Susan Zolla-Pazner Icahn School of Medicine at Mount Sinai
Abraham Pinter
Abraham Pinter Rutgers, The State University of New Jersey
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Shan Lu
Shan Lu University of Massachusetts Chan Medical School
Shixia Wang
Shixia Wang University of Massachusetts Chan Medical School
John R. Mascola
John R. Mascola ModeX Therapeutics
Joseph Sodroski
Joseph Sodroski Harvard Medical School
David C. Montefiori
David C. Montefiori Duke University
Leonidas Stamatatos
Leonidas Stamatatos Fred Hutchinson Cancer Research Center
Barton F. Haynes
Barton F. Haynes Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare pathways often lead to nursing and specialized clinical roles. Pursuing an accelerated nursing program can be a strategic move, and students often search for options like accelerated nursing programs near me to find accessible paths to a Bachelor of Science in Nursing (BSN). These programs provide a solid foundation in patient care and biomedical sciences, complementing immunology knowledge.

Many aspiring nurses also explore easy admission lpn programs to enter the workforce quickly. Licensed Practical Nurse (LPN) programs offer practical skills and clinical experience, making them suitable entry points for careers involving immune system-related health issues.

Advanced degrees like those for nurse practitioners offer further specialization. Students looking for less competitive routes might consider nurse practitioner programs with easy admission, which can open doors to roles that closely collaborate with immunologists on patient care, diagnostics, and treatment strategies.

For those interested in mental health nursing, programs such as the best online pmhnp programs not only offer excellent clinical placements but also provide vital experience in psychiatric and mental health settings where immune responses are increasingly recognized as factors in care.

Best Scientists Citing Miroslaw K. Gorny

Trending Scientists

Recently Published Articles